Last updated on September 2018

Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia

Brief description of study

The purpose of this study is to evaluate the efficacy and safety of MT-5199 administered once daily for the treatment of Tardive Dyskinesia (TD) symptoms.

Clinical Study Identifier: NCT03176771

Contact Investigators or Research Sites near you

Start Over

Clinical Trials Information Desk, to ...

Shiga University of Medical Science Hospital
Shiga, Japan
  Connect »

Clinical Trials Information Desk, to ...

Sagaarashiyama Tanaka Clinic
Kyoto, Japan
  Connect »